Dr. Michael Schutz, M.D

NPI: 1104872167
Total Payments
$3,165
2024 Payments
$389.24
Companies
38
Transactions
138
Medicare Patients
4,201
Medicare Billing
$391,871

Payment Breakdown by Category

Food & Beverage$3,065 (96.8%)
Consulting$100.00 (3.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,065 137 96.8%
Consulting Fee $100.00 1 3.2%

Top Paying Companies

Company Total Records Latest Year
Astellas Pharma US Inc $292.47 20 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $269.08 8 $0 (2024)
Janssen Biotech, Inc. $250.63 12 $0 (2022)
Medtronic USA, Inc. $245.13 3 $0 (2019)
ABBVIE INC. $191.22 14 $0 (2024)
Boston Scientific Corporation $181.08 3 $0 (2019)
Palette Life Sciences, Inc. $179.48 4 $0 (2022)
NeoTract Inc. $137.38 2 $0 (2018)
Daiichi Sankyo Inc. $113.85 6 $0 (2024)
PFIZER INC. $105.63 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $389.24 21 Daiichi Sankyo Inc. ($60.22)
2023 $338.83 20 Astellas Pharma US Inc ($65.95)
2022 $595.73 32 Palette Life Sciences, Inc. ($179.48)
2021 $153.16 9 Medtronic, Inc. ($41.48)
2020 $43.06 3 Amgen Inc. ($43.06)
2019 $514.35 6 Boston Scientific Corporation ($181.08)
2018 $278.05 11 NeoTract Inc. ($111.70)
2017 $852.49 36 Janssen Biotech, Inc. ($185.11)

All Payment Transactions

138 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
09/23/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $14.94 General
Category: Oncology
09/16/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $16.67 General
Category: ONCOLOGY
09/06/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $16.98 General
Category: Oncology
09/04/2024 Stemline Therapeutics Inc. Orserdu (Drug) Food and Beverage In-kind items and services $16.94 General
Category: Oncology
08/27/2024 JAZZ PHARMACEUTICALS INC. ZEPZELCA (Drug) Food and Beverage In-kind items and services $18.94 General
Category: HEMATOLOGY/ONCOLOGY
08/23/2024 ABBVIE INC. LUPRON DEPOT (Drug) Food and Beverage In-kind items and services $18.59 General
Category: ENDOCRINOLOGY
08/19/2024 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $18.60 General
Category: Iron Deficiency Anemia
07/29/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $14.45 General
Category: HORMONE THERAPY
07/16/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $18.98 General
Category: Oncology
06/25/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $24.95 General
Category: ONCOLOGY
06/11/2024 Novocure Inc. Optune (Device) Food and Beverage Cash or cash equivalent $24.26 General
Category: Oncology
06/06/2024 Stemline Therapeutics Inc. Orserdu (Drug) Food and Beverage In-kind items and services $16.05 General
Category: Oncology
05/23/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $17.56 General
Category: ONCOLOGY
05/06/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $13.93 General
Category: Oncology
04/05/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $24.80 General
Category: ONCOLOGY
03/15/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $17.35 General
Category: Oncology
03/12/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $13.77 General
Category: Oncology
03/08/2024 Novocure Inc. Optune (Device) Food and Beverage Cash or cash equivalent $32.06 General
Category: Oncology
01/22/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $13.31 General
Category: Oncology
01/18/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $19.69 General
Category: ONCOLOGY
01/17/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $16.42 General
Category: Oncology
12/13/2023 Astellas Pharma US Inc Padcev (Drug) Food and Beverage In-kind items and services $16.66 General
Category: Oncology
12/08/2023 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $24.95 General
Category: ONCOLOGY
11/09/2023 MorphoSys, US Inc. MONJUVI (Drug) Food and Beverage In-kind items and services $16.10 General
Category: Oncology
10/26/2023 Lilly USA, LLC VERZENIO (Drug), JAYPIRCA Food and Beverage In-kind items and services $17.00 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 632 689 $144,073 $55,779
2022 17 885 1,002 $195,075 $83,187
2021 25 1,121 3,571 $296,859 $115,929
2020 29 1,563 3,780 $396,754 $136,975
Total Patients
4,201
Total Services
9,042
Medicare Billing
$391,871
Procedure Codes
92

All Medicare Procedures & Services

92 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 147 178 $31,414 $12,567 40.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 86 98 $21,479 $9,997 46.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 59 59 $18,860 $7,581 40.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 64 64 $13,924 $5,623 40.4%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2023 27 27 $13,500 $5,311 39.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 27 27 $6,711 $2,996 44.6%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 52 62 $4,693 $2,576 54.9%
52000 Diagnostic exam of bladder and urethra using an endoscope Facility 2023 35 35 $8,879 $2,086 23.5%
76770 Complete ultrasound scan behind abdominal cavity Office 2023 20 20 $4,000 $1,916 47.9%
76856 Complete ultrasound scan of pelvis Office 2023 18 19 $3,800 $1,679 44.2%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 18 18 $3,569 $1,275 35.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 11 12 $1,582 $809.64 51.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 11 12 $2,200 $592.32 26.9%
51784 Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings Office 2023 12 12 $4,800 $496.02 10.3%
51741 Electronic assessment of bladder emptying Office 2023 20 20 $4,000 $150.94 3.8%
51741 Electronic assessment of bladder emptying Facility 2023 25 26 $661.98 $122.16 18.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 180 225 $31,424 $16,670 53.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 111 149 $29,757 $15,973 53.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 65 65 $19,784 $8,971 45.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 69 69 $14,382 $6,401 44.5%
51728 Complex measurement of pressure of urine flow in bladder with voiding pressure studies Office 2022 16 16 $9,600 $5,347 55.7%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 40 41 $9,740 $4,688 48.1%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2022 21 21 $10,500 $4,478 42.6%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 73 93 $6,582 $3,008 45.7%
52000 Diagnostic exam of bladder and urethra using an endoscope Facility 2022 51 52 $14,691 $2,954 20.1%

About Dr. Michael Schutz, M.D

Dr. Michael Schutz, M.D is a Urology healthcare provider based in Somers Point, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104872167.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Schutz, M.D has received a total of $3,165 in payments from pharmaceutical and medical device companies, with $389.24 received in 2024. These payments were reported across 138 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($3,065).

As a Medicare-enrolled provider, Schutz has provided services to 4,201 Medicare beneficiaries, totaling 9,042 services with total Medicare billing of $391,871. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Location Somers Point, NJ
  • Active Since 05/25/2006
  • Last Updated 02/24/2011
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1104872167

Products in Payments

  • INTERSTIM (Device) $286.61
  • ZYTIGA (Drug) $223.80
  • KEYTRUDA (Biological) $203.06
  • Xofigo (Drug) $169.41
  • Xtandi (Drug) $157.22
  • REZUM (Device) $154.68
  • UroLift (Device) $111.70
  • XTANDI (Drug) $103.57
  • LUPRON DEPOT (Drug) $98.68
  • Nubeqa (Drug) $79.88
  • PROVENGE (Drug) $77.76
  • JAKAFI (Drug) $70.70
  • Androgel (Drug) $69.12
  • Enhertu (Drug) $66.57
  • VERZENIO (Drug) $64.51
  • Optune (Device) $56.32
  • Padcev (Drug) $48.84
  • CALQUENCE (Drug) $48.16
  • Myrbetriq (Drug) $47.29
  • INJECTAFER (Drug) $47.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Somers Point